Challenges in lung cancer therapy during the COVID-19 pandemic

Lancet Respir Med. 2020 Jun;8(6):542-544. doi: 10.1016/S2213-2600(20)30170-3. Epub 2020 Apr 9.

¹ Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy.
² Centre Hospitalier Universitaire Vaudois, Oncology Department, Lausanne University, Lausanne, Switzerland.
³ Gustave Roussy Cancer Campus, Villejuif, France; Université Paris-Saclay, Orsay, France.
⁴ Gustave Roussy Cancer Campus, Villejuif, France; Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France.
⁵ Radiology Unit, Rugani Hospital, Siena, Italy.
⁶ Division of Medical Oncology, S.G. Moscati Hospital, Avellino, Italy.
⁷ LungenClinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany.
⁸ Division of Hematology/Oncology, Department of Medicine, Columbia University, New York, NY, USA.
⁹ Center for Immuno-Oncology, Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, 53100 Siena, Italy; NIBIT Foundation Onlus, Siena, Italy. Electronic address: mmaiocro@gmail.com.

No abstract available

MeSH terms